Ethyl 34-dihydroxybenzoate

CAS No. 3943-89-3

Ethyl 34-dihydroxybenzoate( —— )

Catalog No. M20341 CAS No. 3943-89-3

Ethyl?34-dihydroxybenzoate?(EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethyl 34-dihydroxybenzoate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethyl?34-dihydroxybenzoate?(EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain.
  • Description
    Ethyl?34-dihydroxybenzoate?(EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    prolyl hydroxylas
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3943-89-3
  • Formula Weight
    182.17
  • Molecular Formula
    C9H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (548.91 mM)
  • SMILES
    CCOC(=O)c1ccc(O)c(O)c1
  • Chemical Name
    Ethyl-34-dihydroxybenzoate; Ethyl protocatechuate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nandan D Clarke E P Ball E H et al. Ethyl-34-dihydroxybenzoate inhibits myoblast differentiation: Evidence for an essential role of collagen[J]. The Journal of Cell Biology 1990 110(5):1673-1679.
molnova catalog
related products
  • ARN19702

    ARN19702 is a selective, orally active, reversible, and brain-penetrant?N-acylethanolamine acid amidase (NAAA)?inhibitor with an?IC50?of 230 nM for?human NAAA. ARN19702 has pain relief effects.

  • [Lys0] - γ - 1 - MSH...

    [Lys0] - γ - 1 - MSH (41 - 58), amide

  • (3beta,7beta,12beta,...

    (3β,7β,12β,20Z)-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid, a lanostane triterpenoid, demonstrates significant inhibitory effects on nitric oxide (NO) production in BV-2 microglia cells induced by n LPS, with an IC50 value of 9.55 uM.